Skip to content
Screener

Assembly Biosciences ASMB Q3 2025 earnings

Reported November 10, 2025 · Before market open

Revenue$10.8MBeat by $3.3M
EPS-$0.72Miss by $0.22
Revenue estimate$7.5M
EPS estimate-$0.50

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$9.1M
EPS estimate-$0.66

Financials

Q3 2025

Income statement

See full
Revenue$10.8M+57.6%
Operating income-$10.9M+0.7%
Net income-$9.2M+4.3%
EPS (diluted)-$0.72+52.3%

Balance sheet

See full
Cash & equivalents$22.5M-20.8%
Total debt$2.8M+91.1%
Total equity$182.7M+603%
Total assets$240.0M+139%

Cash flow

See full
Operating cash flow-$15.1M+0.7%
CapEx$42.0K—
Free cash flow-$15.2M+0.5%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$196.41M+104%
Enterprise value$176.63M+156%
P/S5.3×+1.9×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity0×0.0×
Current ratio4.4×+2.1×

FAQ

When did Assembly Biosciences report Q3 2025 earnings?
Assembly Biosciences (ASMB) reported Q3 2025 earnings on November 10, 2025 before market open.
What were Assembly Biosciences's Q3 2025 revenue and EPS?
Assembly Biosciences reported revenue of $10.8M and eps of $-0.72 for Q3 2025.
Did Assembly Biosciences beat estimates in Q3 2025?
Revenue beat the consensus estimate of $7.5M by $3.3M. EPS missed the consensus estimate of $-0.50 by $0.22.
How did Assembly Biosciences's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 57.6% from $6.8M a year earlier and eps grew 52.3% from $-1.51.
Where can I find Assembly Biosciences's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-274235) and the 10-Q periodic report (0001193125-25-274277) directly on SEC EDGAR. The filing index links above go to sec.gov.